ChemoCentryx, Inc.

CCXI · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$132-$55-$55-$38
Dep. & Amort.$3$1$2$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$31$23$12$11
Change in WC$16-$53-$26$44
Other Non-Cash$6$3-$1-$1
Operating Cash Flow-$76-$81-$70$16
Investing Activities
PP&E Inv.-$19-$15-$1-$1
Net Acquisitions-$92$0$0$0
Inv. Purchases-$307-$446-$212-$192
Inv. Sales/Matur.$419$179$200$140
Other Inv. Act.$92$0$0$0
Investing Cash Flow$92-$282-$13-$53
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$7$326$73$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$357$95$25
Financing Cash Flow$1$357$95$25
Forex Effect$0$0$0$0
Net Chg. in Cash$18-$7$12-$12
Supplemental Information
Beg. Cash$33$40$28$40
End Cash$51$33$40$28
Free Cash Flow-$95-$97-$71$16
ChemoCentryx, Inc. (CCXI) Financial Statements & Key Stats | AlphaPilot